Maya Beganovic, PharmD, MPH

U.S. Food and Drug Administration
Buffalo Grove, Illinois, United States

Disclosure information not submitted.

Presentation(s):

• 551 - A Multistate Investigation of Serious Adverse Events, Including Deaths, Following Ceftriaxone Injections, September 2024–June 2025

  Wednesday, October 22, 2025
  11:30 AM - 11:42 AM US ET